 |
|
|
|
|
Argos Overview
Argos Therapeutics is an immunotherapy company developing new treatments for cancer,
infectious, inflammatory and autoimmune diseases, and transplantation rejection. The Company has
generated multiple platform technologies and a diverse pipeline of products based on
its expertise in the biology of dendritic cells – the master switch that turns
the immune system on or off.
Argos, a private biotechnology company, is headquartered
in Research Triangle Park, NC. The Company has clinical trial programs
in metastatic renal cell carcinoma (RCC), human immunodeficiency virus (HIV) and systemic lupus erythematosus (SLE).
Product Pipeline
View
a list of upcoming conferences in which Argos will participate.
If you are interested in discussing investment opportunities with Argos Therapeutics,
please contact us at businessdev@argostherapeutics.com.
|
|
 |
|
